USFDA grants Zydus fast track designation for Saroglitazar to treat primary biliary cholangitis EP News Bureau Dec 9, 2020 Zydus announced that the United States Food and Drug Administration (USFDA) has granted ‘Fast Track Designation’ to Saroglitazar…
